| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | ATP dependent helicase SMARCA2; ATP-dependent helicase SMARCA2; BAF190; BAF190B; BRG1-associated factor 190B; BRM; FLJ36757; Global transcription activator homologous sequence; hBRM; hSNF2a; MGC74511; Possible global transcription activator SNF2L2; Probable global transcription activator SNF2L2; Protein brahma homolog; SMARCA2; SMCA2_HUMAN; SNF2 alpha; SNF2 like 2; SNF2-alpha; SNF2/SWI2 like protein 2; SNF2L2; SNF2LA; Sth1p; Sucrose nonfermenting 2 like protein 2; SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily A member 2; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 |
| Clonality | |
| Conjugate | |
| Form | Liquid |
| Host | |
| Immunogen | Recombinant Human Probable global transcription activator SNF2L2 protein (700-1216AA) |
| Isotype | |
| Product Type | |
| Reactivity | |
| Source | This product is a polyclonal antibody purified from rabbit antiserum. |
| Storage | |
| Target | |
| UniProt # |
Overview
This is a polyclonal anti-SMARCA2 antibody raised in Rabbit, with confirmed utility in ELISA, IHC, ChIP. Designed to detect SMARCA2 in Human, supporting researchers in epigenetics and nuclear signaling contexts.
Key elements and design rationale
- Immunogen: Recombinant Human Probable global transcription activator SNF2L2 protein (700-1216AA) — determines the epitope region recognized; confirm epitope compatibility with your sample preparation and expected PTMs.
- Host (Rabbit): Requires anti-rabbit-IgG secondary reagents. Mismatched secondaries result in no signal. Consider host species when multiplexing.
- Polyclonal: Recognizes multiple epitopes — robust signal across varied preparations, with inherent lot-to-lot variability. Isotype controls and lot qualification recommended.
- Isotype (IgG): Secondary antibodies and isotype controls must match IgG from Rabbit. Relevant for multiplexing and Protein A/G compatibility.
- Purification (Protein G purification): Reduces non-specific immunoglobulin populations, improving signal-to-noise in quantitative immunoassay formats.
Biological background
SMARCA2 (also known as ATP dependent helicase SMARCA2, ATP-dependent helicase SMARCA2, BAF190, BAF190B, BRG1-associated factor 190B, BRM, FLJ36757, Global transcription activator homologous sequence, hBRM, hSNF2a, MGC74511, Possible global transcription activator SNF2L2, Probable global transcription activator SNF2L2, Protein brahma homolog, SMARCA2, SMCA2_HUMAN, SNF2 alpha, SNF2 like 2, SNF2-alpha, SNF2/SWI2 like protein 2, SNF2L2, SNF2LA, Sth1p, Sucrose nonfermenting 2 like protein 2, SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily A member 2, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2) is a protein studied in Human systems. Expression levels, subcellular localization, and post-translational modifications vary across cell types, tissues, and disease states — factors that influence antibody-based detection outcomes. Researchers are encouraged to consult UniProt, NCBI Gene, and primary literature for current annotation of SMARCA2 biology relevant to epigenetics and nuclear signaling.
Common research applications
- ELISA: Sandwich or indirect ELISA quantifies soluble/secreted target in biological fluids or cell culture supernatants.
- IHC: IHC visualizes target expression in FFPE or frozen sections; optimize antigen retrieval and secondary detection per tissue type.
- ChIP: IP enriches target-containing complexes from lysates; antibody binding efficiency under native conditions should be confirmed.
Notes for experimental interpretation
- Isotype controls: Include IgG from Rabbit at equivalent concentration to assess non-specific background.
- Cross-reactivity/isoforms: Polyclonal preparations may cross-react with related proteins or isoforms — validate with siRNA KD, KO lysate, or recombinant protein controls.
- Matrix effects: Sample matrix (serum, plasma, lysate, homogenate) may influence performance; pilot dilution linearity and spike-recovery experiments before full quantitative studies.
- Species reactivity: Confirmed for Human; extrapolation to untested species requires empirical validation.
This product is a polyclonal antibody purified from rabbit antiserum.
SMARCA2 is a protein target in Human biology. This polyclonal antibody raised in Rabbit detects SMARCA2 and is validated for ELISA, IHC, ChIP applications.
This antibody is reported reactive against Human. Immunogen derived from Human. Cross-reactivity with unlisted species should not be assumed — contact us or consult the datasheet for homology data.
Supplier reports performance in ELISA, IHC, ChIP. Dilution optimization, blocking, and appropriate controls are required per format. Contact BioHippo for recommended working concentrations.
This non-conjugated (IgG) antibody requires a secondary anti-rabbit IgG conjugated to HRP, AP, fluorophore, or biotin. Match the secondary to the host (Rabbit) and isotype (IgG).
(1) Isotype control — IgG from Rabbit at matching concentration; (2) Positive control — lysate/cell line expressing SMARCA2; (3) Negative control — siRNA KD or KO sample to confirm specificity; (4) Dilution linearity — verify proportional signal decrease for quantitative applications.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
